The Food and Drug Administration this week authorized several SARS-CoV-2 serial screening tests for asymptomatic individuals. They include two over-the-counter tests for use at home; one over-the-counter test for use at home with a telehealth proctor; one over-the-counter test for point-of-care settings; and one prescription test for point-of-care settings. 

FDA previously authorized the tests for individuals with COVID-19 symptoms. 

“The addition of the OTC and POC tests for screening will give schools, workplaces, communities and others several options for serial screening tests that are accurate and reliable,” FDA said.
 

Related News Articles

Blog
The Centers for Medicare & Medicaid Services recently announced that Medicare will not continue to cover audio-only telehealth visits when the COVID-19…
Headline
In this AHA video for Mother’s Day, part of AHA’s #MyWhy social media campaign, a pregnant health care worker explains why she chose to get…
Headline
Moderna Inc. told investors today that is intends to soon file for full Food and Drug Administration approval for its COVID-19 vaccine. Moderna, whose…
Headline
AHA yesterday urged the Department of Health and Human Services to extend the deadline for hospitals and other health care providers to use their COVID-19…
Blog
In this update to his September 2020 blog post, Mike Schiller, senior director of supply chain for the AHA’s Association for Health Care Resource and Materials…
Headline
The AHA today donated to UNICEF to help hospitals and communities fight a devastating surge in COVID-19 cases in India. UNICEF is rushing urgently needed…